Zimmer Biomet asks European hospitals to remove orthopedic spacer molds

Alan Condon -   Print  |

Zimmer Biomet on March 10 issued an urgent field safety notice to European hospitals requesting the removal of the company's StageOne and StageOne Select bone cement spacer molds.

The notice intends to prevent the use of some implants, which may have been improperly cleaned and monitored.

Zimmer Biomet received five complaints that may be linked to the issue, which could result in an adverse local tissue reaction, pains and potential reactions to allergens or toxins.

More than 230,000 implants have been distributed.

Zimmer Biomet did not respond to a request for comment March 18.

More articles on devices:
8 of the biggest whistleblower cases in spine, orthopedics this year
Outpatient joint replacements to 'skyrocket over next 10 years,' says Dr. Richard Berger
Centinel Spine founder leaves to grow other business; Steven Murray named CEO

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers